Craig-Hallum raised the firm’s price target on Xeris Biopharma (XERS) to $6.50 from $5 and keeps a Buy rating on the shares following strong Q4 ...

Craig-Hallum analyst Anthony Stoss lowered the firm’s price target on Samsara (IOT) to $42 from $48 and keeps a Hold rating on the shares. The ...

Fintel reports that on February 28, 2025, Craig-Hallum initiated coverage of MediWound (NasdaqGM:MDWD) with a Buy ...

Fintel reports that on February 12, 2025, Craig-Hallum initiated coverage of Myriad Genetics (NasdaqGS:MYGN) with a Buy recommendation. Analyst Price Forecast Suggests 57.19% Upside As of January 29, ...

https://www.tipranks.com/news/the-fly/doubleverify-price-target-lowered-to-24-from-28-at-bmo-capital As previously reported, Craig-Hallum downgraded Akamai (AKAM) to ...

As previously reported, Craig-Hallum analyst Albert Lowe initiated coverage of Eupraxia Pharmaceuticals (EPRX) with a Buy ...

Airgain (NASDAQ:AIRG – Free Report) had its price objective reduced by Craig Hallum from $12.00 to $9.00 in a research report report published on Friday morning,Benzinga reports. Craig Hallum ...

Fintel reports that on January 21, 2025, Craig-Hallum initiated coverage of Core Scientific, Inc. - Equity Right (OTCPK:CORZR) with a Buy recommendation. As of December 3, 2024, the average one ...

Arlo Technologies (NYSE:ARLO – Get Free Report) had its price target lifted by investment analysts at Craig Hallum from ...

As of February 19, 2025, the average one-year price target for MediWound is $29.58/share. The forecasts range from a low of $25.25 to a high of $37.80. The average price target represents an ...